Source:http://linkedlifedata.com/resource/pubmed/id/15665753
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2005-1-24
|
pubmed:abstractText |
The effects of hematocrit (Ht) value on microparticle enzyme immunoassay (MEIA) of tacrolimus concentration were examined in 1063 whole-blood samples from 42 transplant recipients (13 liver, 20 kidney, and 9 bone marrow transplantations). MEIA guarantees the test's assay quality for blood tacrolimus in samples with Ht values of 25% to 45%. However, 129 samples (29.3%) obtained from liver transplant recipients and 107 samples (61.5%) from bone marrow transplant recipients had lower Ht (<25%). Further, 81 blood samples (18.1%) with Ht > 45% were observed in kidney transplant patients. Twenty-five whole-blood samples with low Ht were tested by 3 assay methods for tacrolimus: MEIA, modified, corrected MEIA (cMEIA), and enzyme-linked immunosorbent assay (ELISA). MEIA gave higher blood concentrations of tacrolimus than ELISA (16.1 versus 11.0 ng/mL, P < 0.001). This difference was generated by overestimation in MEIA and was not observed in samples with normal Ht. This overestimation was eliminated by using cMEIA on samples with low Ht values: there was no difference in blood tacrolimus concentration between cMEIA and ELISA (12.3 versus 11.0 ng/mL). ELISA or cMEIA should be used for tacrolimus assay in samples obtained from bone marrow transplant recipients with anemia and from liver and kidney transplant recipients with unstable Ht values.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0163-4356
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
27
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
94-7
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:15665753-Bone Marrow Transplantation,
pubmed-meshheading:15665753-Child, Preschool,
pubmed-meshheading:15665753-Drug Monitoring,
pubmed-meshheading:15665753-Female,
pubmed-meshheading:15665753-Hematocrit,
pubmed-meshheading:15665753-Humans,
pubmed-meshheading:15665753-Immunoenzyme Techniques,
pubmed-meshheading:15665753-Immunosuppressive Agents,
pubmed-meshheading:15665753-Kidney Transplantation,
pubmed-meshheading:15665753-Liver Transplantation,
pubmed-meshheading:15665753-Male,
pubmed-meshheading:15665753-Predictive Value of Tests,
pubmed-meshheading:15665753-Tacrolimus,
pubmed-meshheading:15665753-Time Factors
|
pubmed:year |
2005
|
pubmed:articleTitle |
Effects of hematocrit value on microparticle enzyme immunoassay of tacrolimus concentration in therapeutic drug monitoring.
|
pubmed:affiliation |
Department of Pharmacy, Tsukuba University Hospital, Tsukuba, Ibaraki 305-8576, Japan.
|
pubmed:publicationType |
Journal Article,
Comparative Study
|